Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: Italy Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20112
20132
20141
20151
20163
20173
20187
20194
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics4
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Novo Nordisk A/S2
Pfizer2
QED Therapeutics, a BridgeBio company2
Quince Therapeutics S.p.A.2
Swedish Orphan Biovitrum2
Alexion Pharmaceuticals, Inc.1
Azafaros B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn29
Nervous System Diseases8
Hematologic Diseases7
Blood Coagulation Disorders5
Coagulation Protein Disorders5
Hemorrhagic Disorders5
Eye Diseases4
Eye Diseases, Hereditary4
Hemophilia A4
Mitochondrial Diseases4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.